1. Updates on Obesity Treatment:

2. Program Goals

3. Progress in Obesity Management and Treatment

4. Obesity-Associated Conditions and Complications

5. Recent Guidelines for Obesity Management

6. Drugs FDA-Approved for Long-term Use in Weight Loss/Weight Management

7. Importance of Diet and Lifestyle Changes

8. FDA Efficacy Benchmarks for Weight Loss Products

9. Predicting Response to Lorcaserin: Weight Loss at 52 Weeks

10. COR-BMOD Trial: Impact of Intensive Behavior Modification with or without Naltrexone SR/Bupropion SR (32 mg/d)

11. Response vs Nonresponse to Weight Loss Medications

12. Setting Weight Loss Expectations

13. Comorbid Conditions Improved by Weight Loss in Obese Individuals

14. Obesity Medicine: A New Subspecialty

15. Individualizing Treatment Selection Based on Comorbidities/Coexisting Conditions: Examplesa,b

17. Maintaining Weight Loss

18. Summary and Closing Comments

19. Abbreviations

20. Abbreviations (cont)

21. References

22. References (cont)

23. References (cont)

24. References (cont)

25. References (cont)

26. References (cont)

27. References (cont)

28. References (cont)